six1 has 136 expression phenotype(s)
Page: 1 2 3 4 5 6 7 8 9 10 11 ???pagination.result.next???
Images Sources Experiment + Assay Phenotypes Human Diseases
Fig. 3A (red)

Mehdizadeh T et al. (2021) 		Xla Wt + six1-150

NF26-32 (head-qPCR)
Expression Phenotype
decreased amount eya2.L expression in head
decreased amount pa2g4.L expression in head
Fig. 2EG

Mehdizadeh T et al. (2021) 		Xla Wt + six1-150

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount prdm1.L expression in otic vesicle
Fig. 2KM

Mehdizadeh T et al. (2021) 		Xla Wt + six1-150

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount tspan13.L expression in otic vesicle
branchiootorenal syndrome
Fig. 2NP

Mehdizadeh T et al. (2021) 		Xla Wt + six1-150

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount pa2g4.L expression in otic vesicle
branchiootorenal syndrome
Fig. 3B (red)

Mehdizadeh T et al. (2021) 		Xla Wt + six1-400

NF26-32 (head-qPCR)
Expression Phenotype
decreased amount pa2g4.L expression in head
Fig 2B

Mehdizadeh T et al. (2021) 		Xla Wt + six1-400

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount eya2.L expression in otic vesicle
Fig. 2HJ

Mehdizadeh T et al. (2021) 		Xla Wt + six1-400

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount spry1.L expression in otic vesicle
branchiootorenal syndrome
Fig. 2IJ

Mehdizadeh T et al. (2021) 		Xla Wt + six1-EnR

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount spry1.L expression in otic vesicle
branchiootorenal syndrome
Fig. 2OP

Mehdizadeh T et al. (2021) 		Xla Wt + six1-EnR

NF26-32 (in situ hybridization)
Expression Phenotype
decreased amount pa2g4.L expression in otic vesicle
branchiootorenal syndrome
Fig 1A

Mehdizadeh T et al. (2021) 		Xla Wt + six1 MO

NF20-22 (in situ hybridization)
Expression Phenotype
decreased amount eya2.L expression in otic placode